4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 3.710
+0.170 (4.80%)
Sep 17, 2026, 11:39 AM AEST
4DMedical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, 4DMedical stock has a consensus rating of "Hold" and an average price target of $4.37. The average 1-year stock price forecast is 17.79% higher than the current stock price, while the lowest is $3.00 (-19.14%) and the highest is $6.00 (+61.73%).
Price Target: $4.37 (+17.79%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for 4DMedical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains $4.10 | Hold | Maintains | $4.10 | +10.51% | Aug 31, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $6.00 | Buy | Maintains | $6.00 | +61.73% | Aug 31, 2026 |
| Ord Minnett | Ord Minnett | Sell Maintains $3.00 | Sell | Maintains | $3.00 | -19.14% | Jun 3, 2026 |
Financial Forecast
Revenue This Year
22.80M
from 7.06M
Increased by 222.88%
Revenue Next Year
55.10M
from 22.80M
Increased by 141.68%
EPS This Year
-0.06
from -0.00
EPS Next Year
-0.02
from -0.06
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.